Following the NASDAQ bell-ringing in New York, ALPS Group is turning its attention back to what matters most — the science, the people, and the purpose.
In an exclusive feature by The Epoch Times, ALPS’ Chairman & CEO Dr. Tham Seng Kong shared his vision for the company:
“We gave up titles, salaries, and comfort to pursue something greater — to make science serve humanity, not the other way around.”
Founded in Malaysia in 2017, ALPS has grown into a leading biotech and life-sciences group focusing on:
- Regenerative & Precision Medicine
- Immunotherapy & Cell-Based Treatments
- mRNA & Genetic Vaccine Research
ALPS’ next chapter builds on its core promise — to make cutting-edge medical technologies accessible, ethical, and sustainable. With its headquarters in Malaysia and a global listing on NASDAQ, ALPS stands as a symbol of Southeast Asia’s growing strength in medical innovation.
🔗 Read the full article: Epoch Times
